Protein Biomarkers Identify Patients Unlikely to Benefit from Primary Prevention ICDs: Findings from the PROSE-ICD Study

BACKGROUND: Primary prevention implantable cardioverter defibrillators (ICDs) reduce all-cause mortality but the benefits are heterogeneous. Current risk stratification based on left ventricular ejection fraction has limited discrimination power. We hypothesize that biomarkers for inflammation, neur...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Circ Arrhythm Electrophysiol
Autores principales: Cheng, Alan, Zhang, Yiyi, Blasco-Colmenares, Elena, Dalal, Darshan, Butcher, Barbara, Norgard, Sanaz, Eldadah, Zayd, Ellenbogen, Kenneth A., Dickfeld, Timm, Spragg, David D., Marine, Joseph E., Guallar, Eliseo, Tomaselli, Gordon F.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2014
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4336541/
https://ncbi.nlm.nih.gov/pubmed/25273351
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCEP.113.001705
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares